{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "22963338", "DateCompleted": {"Year": "2013", "Month": "06", "Day": "10"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "30"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "1876-1038", "JournalIssue": {"Volume": "7", "Issue": "4", "PubDate": {"Year": "2012", "Month": "Nov"}}, "Title": "Reviews on recent clinical trials", "ISOAbbreviation": "Rev Recent Clin Trials"}, "ArticleTitle": "Application of ozone therapy in the vestibulocochlear syndrome.", "Pagination": {"StartPage": "321", "EndPage": "328", "MedlinePgn": "321-8"}, "Abstract": {"AbstractText": ["The aim of this study was to evaluate the efficacy of ozone therapy in the treatment of 50 patients with peripheral vestibulocochlear syndrome. Ozone was injected in the cervical region C2-C3, for 20 sessions. Evaluation criteria was based in the evolution of nystagmus, tinnitus, hearing loss and vertigo. Also, oxidative stress parameters were measured. Results demonstrated that patient improvements, according to vertigo, hearing loss, tinnitus and nystagmus, were of 90, 80, 65 and 100%, respectively. These patients were initially under condition of systemic oxidative stress, however, at the end of the study a redox balance was achieved. No side effects were observed."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Ozone Research Center, National Center for Scientific Research, Havana City, Cuba. silviamenendez@infomed.sld.cu"}], "Identifier": [], "LastName": "Men\u00e9ndez", "ForeName": "Silvia", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Del Cerro", "ForeName": "Alejandro", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Alvarez", "ForeName": "Tania", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Hern\u00e1ndez", "ForeName": "Francisco", "Initials": "F"}], "PublicationTypeList": ["Clinical Trial", "Journal Article"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Rev Recent Clin Trials", "NlmUniqueID": "101270873", "ISSNLinking": "1574-8871"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Ear"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Hearing Disorders"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Postural Balance"}, {"QualifierName": [], "DescriptorName": "Prospective Studies"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Sensation Disorders"}, {"QualifierName": [], "DescriptorName": "Syndrome"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2012", "Month": "4", "Day": "2"}, {"Year": "2012", "Month": "7", "Day": "31"}, {"Year": "2012", "Month": "8", "Day": "1"}, {"Year": "2012", "Month": "9", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2012", "Month": "9", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2013", "Month": "6", "Day": "12", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["22963338", "10.2174/1574887111207040321", "RRCT-EPUB-20120907-1"]}}], "PubmedBookArticle": []}